Wikipedia
Novo Nordisk is the largest pharmaceutical company in Denmark Novo Nordisks market capitalization exceeded the GDP of Denmarks domestic economy in 2023 and it is. Novo Nordisk AS is a Danish multinational pharmaceutical company It has factories in in nine countries More than 48000 people work for the company. The Novo Nordisk Foundation is an international enterprise foundation focusing on medical treatment and research In 2022 the foundation had a net worth of 107 billion 805 billion. In 2012 a team of researchers at Novo Nordisk developed semaglutide for a once-weekly diabetes therapy as a longer-acting alternative to liraglutide It was given the brand name Ozempic. We are a proud life science company united by a common job to discover better treatments for people living with a serious chronic disease..
Track Novo Nordisk AS NVO Stock Price Quote latest community messages chart news and other stock related information Share your ideas and get valuable insights from the. Novo Nordisk AS NVO NYSE - NYSE Delayed Price. Novo Nordisk AS NVO NYSE - Nasdaq Real Time Price. Capital Investment Advisory Services LLC increased its position in shares of Novo Nordisk AS NYSENVO Free Report by 253 in the 3rd quarter according to the company in its most recent. Novo Nordisk - ADR 52 week high is 10898 as of January 20 2024 What is the 52-week low for Novo Nordisk - ADR 52 week low is the lowest price of a stock in the past 52 weeks or one year..
Given the above assumptions I calculate a base-case target price for Novo Nordisk of about. The weighted average target price per Novo Nordisk share in Feb 2025 is. The 25 analysts offering 12-month price forecasts for Novo Nordisk AS have a median target of 11676. With these updated EPS projections Ive calculated a fair implied share price for Novo Nordisk at. Based on short-term price targets offered by four analysts the average price target for. 14-Dec-23 18-Jan-24 25-Jan-24 Select bar for recommendation details. Analyst Ratings Novo Nordisk Stock Forecast All Analysts Top Analysts Stock Price Forecast The 5..
According to the issued ratings of 8 analysts in the last year the consensus rating for Novo Nordisk AS stock is Moderate Buy based on the. Based on short-term price targets offered by four analysts the average price target for Novo Nordisk comes to 12005. The 25 analysts offering 12-month price forecasts for Novo Nordisk AS have a median target of 11676 with a high estimate of 12881 and a low. 8 brokers have issued 1 year price objectives for Novo Nordisk ASs shares Their NVO share price targets range from 11000 to 14000. Share price forecast in DKK The 24 analysts offering 12 month price targets for Novo Nordisk AS have a median target of 79700 with a high..
Wikipedia
Komentar